X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 60 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,473 | -43.8% | 17,865 | 0.0% | 0.01% | -28.6% |
| Q2 2023 | $34,658 | +11.5% | 17,865 | -50.0% | 0.01% | 0.0% |
| Q1 2023 | $31,085 | -12.4% | 35,730 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $35,480 | -41.8% | 35,730 | 0.0% | 0.01% | -38.5% |
| Q3 2022 | $61,000 | +79.4% | 35,730 | 0.0% | 0.01% | +85.7% |
| Q2 2022 | $34,000 | -46.0% | 35,730 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $63,000 | -23.2% | 35,730 | 0.0% | 0.01% | -15.4% |
| Q4 2021 | $82,000 | -56.6% | 35,730 | 0.0% | 0.01% | -58.1% |
| Q3 2021 | $189,000 | -18.5% | 35,730 | 0.0% | 0.03% | -11.4% |
| Q2 2021 | $232,000 | -62.3% | 35,730 | -50.0% | 0.04% | -34.0% |
| Q1 2021 | $616,000 | +167.8% | 71,460 | +100.0% | 0.05% | +17.8% |
| Q4 2020 | $230,000 | -5.0% | 35,730 | 0.0% | 0.04% | +4.7% |
| Q3 2020 | $242,000 | -27.3% | 35,730 | 0.0% | 0.04% | -27.1% |
| Q2 2020 | $333,000 | -6.7% | 35,730 | 0.0% | 0.06% | -36.6% |
| Q1 2020 | $357,000 | -6.5% | 35,730 | 0.0% | 0.09% | +55.0% |
| Q4 2019 | $382,000 | – | 35,730 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |